These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1862206)

  • 1. Reliability, validity, and a total score cutoff for the dyskinesia identification system: condensed user scale (DISCUS) with mentally ill and mentally retarded populations.
    Sprague RL; Kalachnik JE
    Psychopharmacol Bull; 1991; 27(1):51-8. PubMed ID: 1862206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dyskinesia Identification System Condensed User Scale (DISCUS): reliability, validity, and a total score cut-off for mentally ill and mentally retarded populations.
    Kalachnik JE; Sprague RL
    J Clin Psychol; 1993 Mar; 49(2):177-89. PubMed ID: 8098048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Dyskinesia Identification System: Condensed User Scale (DISCUS).
    Sprague RL; Kalachnik JE; Slaw KM
    Ment Retard; 1989 Jun; 27(3):141-8. PubMed ID: 2739567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS).
    Matson JL; Fodstad JC; Rivet TT
    J Intellect Dev Disabil; 2008 Dec; 33(4):337-44. PubMed ID: 19039694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.
    Bailey LG; Maxwell S; Brandabur MM
    Psychopharmacol Bull; 1997; 33(1):177-81. PubMed ID: 9133772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic dyskinesia examination of profoundly mentally retarded persons: cooperation and assessment.
    Granger DA; Yurkunski JM; Miller NH; Swanson JM; Crinella FC
    Am J Ment Defic; 1987 Sep; 92(2):155-60. PubMed ID: 2893551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of tardive dyskinesia as measured on the Dyskinesia Identification System--Coldwater.
    Bostrom AC; Walker MK
    Nurs Res; 1990; 39(5):274-9. PubMed ID: 2399131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A psychometric evaluation of a Swedish version of the psychopathology inventory for mentally retarded adults (PIMRA).
    Gustafsson C; Sonnander K
    Res Dev Disabil; 2005; 26(2):183-201. PubMed ID: 15590248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia associated with metoclopramide in persons with developmental disabilities.
    Matson JL; Mayville EA; Bielecki J; Smalls Y; Eckholdt CS
    Res Dev Disabil; 2002; 23(3):224-33. PubMed ID: 12102590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arm tremor, tardive dyskinesia, and mental retardation.
    van Emmerik RE; Sprague RL; Newell KM
    Am J Ment Retard; 1993 Jul; 98(1):74-83. PubMed ID: 8103999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of postural sway patterns in tardive dyskinesia.
    van Emmerik RE; Sprague RL; Newell KM
    Mov Disord; 1993 Jul; 8(3):305-14. PubMed ID: 8101968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a screening program for tardive dyskinesia: feasibility issues.
    Whall AL; Engle V; Edwards A; Bobel L; Haberland C
    Nurs Res; 1983; 32(3):151-6. PubMed ID: 6133266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients].
    Inada T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):181-5. PubMed ID: 8962437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between kinematic and rating scale measures of tardive dyskinesia in a developmentally disabled population.
    Sprague RL; Korach MS; van Emmerik RE; Newell KM
    J Nerv Ment Dis; 1993 Jan; 181(1):42-7. PubMed ID: 8093476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of tardive dyskinesia in a mentally retarded population.
    Richardson MA; Haugland G; Pass R; Craig TJ
    Psychopharmacol Bull; 1986; 22(1):243-9. PubMed ID: 3726070
    [No Abstract]   [Full Text] [Related]  

  • 17. Five-year follow-up study of tardive dyskinesia.
    Gardos G; Cole JO; Perenyi A; Casey DE; Samu I; Kallos M; Schniebolk S
    Adv Biochem Psychopharmacol; 1985; 40():37-42. PubMed ID: 2862767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group.
    van Os J; Walsh E; van Horn E; Tattan T; Bale R; Thompson SG
    Acta Psychiatr Scand; 2000 Apr; 101(4):300-6. PubMed ID: 10782550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of Activity in Profound/Severe Mental Retardation (LAPMER): a Rasch-derived scale of disability.
    Tesio L; Valsecchi MR; Sala M; Guzzon P; Battaglia MA
    J Appl Meas; 2002; 3(1):50-84. PubMed ID: 11997585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of personal competence of mentally retarded individuals.
    Reynolds WM
    Am J Ment Defic; 1981 Jan; 85(4):368-76. PubMed ID: 7457501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.